An introduction to medicinal cannabis

The number of Australians being prescribed medicinal cannabis is increasing rapidly. Over the 12-month period to 31 January 2020, the Therapeutic Goods Administration approved 27,658 Category B applications for unapproved medicinal cannabis products.¹ This represents a dramatic increase compared with 3,173 such applications in the previous 12 months.²

In light of this emerging field of medicine, Guild Learning and Development has partnered with BioCeuticals in the development of a new comprehensive online module titled An introduction to medicinal cannabis. This practice-focused module is a great way to equip pharmacists with the essential knowledge and skills for delivering patient care in this important new therapy area.

The module introduces the therapeutic uses and regulatory aspects of cannabis, including the mechanisms of action, pharmacokinetic profile, safety and practical considerations for pharmacists in supplying medicinal cannabis and counselling patients.

This activity has been accredited for 1.5 hours of Group 1 CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities.

To enrol in this course please visit guilded.guild.org.au

Please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au for more information.

Guild Learning and Development thanks BioCeuticals for their financial support and assistance in the development of this course.

G2019056

1. Therapeutic Goods Administration. Access to medicinal cannabis products, 2019 [accessed 2 March 2020]. Available from: https://www.tga.gov.au/access-medicinal-cannabis-products-1.
2. Paola S. How many Australians are accessing unapproved medicinal cannabis? 19 Feb 2019 [accessed 2 March 2019] https://ajp.com.au/news/how-many-australians-are-accessing-unapproved-medicinal-cannabis/